BAYER will invest $2.2 billion in a new pharmaceutical manufacturing campus in US. ๐บ๐ธ ๐ฉ๐ช
Saying tariffs have nothing to do with this is wrong. Decision to invest in US was made at a time when US is encouraging companies to invest locally rather than manufacture somewhere else and ship to the United States.
German company also has good reasons not to acknowledge this publicly, as this would cause a political problem that could encourage other governments to do the same. However, other countries don't have the leverage that US has because of the size of its economy.